Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Endovascular Therapy With Intra-Arterial Thrombolysis for Medium Vessel Occlusion Stroke--the IAT-MeVO Trial

NCT07336927 is registered in ClinicalTrials.gov with Bo Wu as lead sponsor.

NCT NCT07336927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07336927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Endovascular Therapy With Intra-Arterial Thrombolysis for Medium Vessel Occlusion Stroke--the IAT-MeVO Trial
Lead sponsor
Bo Wu
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
December 31, 2030
Enrollment
614 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke due to medium-vessel-occlusion